📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Nanobiotix

1.1 - Company Overview

Nanobiotix Logo

Nanobiotix

Headquarter: France
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of nanomedicine therapeutics for the local treatment of cancer. Develops NanoXray, a technology using inert particles to destroy cancer cells. Products include magnetic particles and laser-activated nanoparticles for treatment and diagnostic. Offers NBTXR3, a radioenhancer that increases radiotherapy dose in tumor cells without affecting surrounding healthy tissues across solid tumors, and leads NANORAY-312, a phase 3 trial in HNSCC.

Products and services

  • NanoXray: An inert-particle-based cancer therapy system that enables destruction of cancer cells, developed within Nanobiotix’s nanomedicine programs for local treatment of cancer
  • NBTXR3: A tumor-localized radioenhancer engineered to increase radiotherapy dose absorption by tumor cells without affecting surrounding healthy tissues, used to treat various solid tumors
  • NANORAY-312: Phase 3 clinical trial evaluating the efficacy and safety of NBTXR3 in patients with head and neck squamous cell carcinoma (HNSCC)

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nanobiotix

RadiaDyne Logo

RadiaDyne

HQ: United States Website
  • Description: Provider of medical diagnostics and devices; privately held.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full RadiaDyne company profile →
IconOVir Bio Logo

IconOVir Bio

HQ: United States Website
  • Description: Provider of preclinical oncolytic virus therapies for cancer, developing ICVB-1042, an oncolytic adenovirus for advanced solid tumors featuring tumor-selective replication, broad tropism, and enhanced tumor cell killing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IconOVir Bio company profile →
Capintec Logo

Capintec

HQ: United States Website
  • Description: Provider of calibration and measurement technologies for nuclear medicine applications, offering advanced technology and services with a commitment to continuous quality improvement, including the Captus® 4000e Thyroid Uptake System for measuring thyroid uptake.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Capintec company profile →
GigaGen Logo

GigaGen

HQ: United States Website
  • Description: Provider of recombinant biotherapeutic discovery and development, advancing a pipeline of first-in-class biotherapeutics, including novel oncology antibody drug combinations and the world's first recombinant polyclonal hyperimmune gammaglobulin.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GigaGen company profile →
Mirati Therapeutics Logo

Mirati Therapeutics

HQ: Canada Website
  • Description: Provider of novel cancer therapeutics in clinical development and commercialization; product candidates include MGCD265, an oral, multi-targeted kinase inhibitor targeting the Met, VEGF, Ron and Tie-2 receptor tyrosine kinases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Mirati Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Nanobiotix

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nanobiotix

2.2 - Growth funds investing in similar companies to Nanobiotix

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nanobiotix

4.2 - Public trading comparable groups for Nanobiotix

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nanobiotix

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nanobiotix

What does Nanobiotix do?

Nanobiotix is a provider of nanomedicine therapeutics for the local treatment of cancer. Develops NanoXray, a technology using inert particles to destroy cancer cells. Products include magnetic particles and laser-activated nanoparticles for treatment and diagnostic. Offers NBTXR3, a radioenhancer that increases radiotherapy dose in tumor cells without affecting surrounding healthy tissues across solid tumors, and leads NANORAY-312, a phase 3 trial in HNSCC.

Who are Nanobiotix's competitors?

Nanobiotix's competitors and similar companies include RadiaDyne, IconOVir Bio, Capintec, GigaGen, and Mirati Therapeutics.

Where is Nanobiotix headquartered?

Nanobiotix is headquartered in France.

How many employees does Nanobiotix have?

Nanobiotix has 1,000 employees 🔒.

When was Nanobiotix founded?

Nanobiotix was founded in 2010 🔒.

What sector and industry vertical is Nanobiotix in?

Nanobiotix is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nanobiotix

Who are the top strategic acquirers in Nanobiotix's sector and industry

Top strategic M&A buyers and acquirers in Nanobiotix's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nanobiotix?

Top strategic M&A buyers groups and sectors for Nanobiotix include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nanobiotix's sector and industry vertical

Which are the top PE firms investing in Nanobiotix's sector and industry vertical?

Top PE firms investing in Nanobiotix's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nanobiotix's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nanobiotix's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nanobiotix's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nanobiotix include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nanobiotix's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nanobiotix?

The key public trading comparables and valuation benchmarks for Nanobiotix include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nanobiotix for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nanobiotix with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nanobiotix's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nanobiotix with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nanobiotix's' sector and industry vertical?

Access recent funding rounds and capital raises in Nanobiotix's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nanobiotix

Launch login modal Launch register modal